Literature DB >> 16798716

Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: A rare, but intriguing association. Two case reports and literature review.

Roberto Manfredi1, Sergio Sabbatani, Leonardo Calza, Francesco Chiodo.   

Abstract

Two very rare case reports of bladder transitional cell carcinoma associated with HIV infection in patients treated with combined antiretroviral therapy are described, and discussed on the ground of the most relevant and updated literature resources. Only 13 cases of vesical carcinoma have been reported to date in the setting of HIV infection, but only 3 anecdotal single reports (the last in the y 2001) described clinical, therapeutic, and outcome issues of this rare disease association in some detail. In our patients, micro- or macro-haematuria was the clue for in-depth diagnosis and prompt treatment, which was limited to multiple local interventions in 1 case, but finally required a radical cystectomy in the second patient. No relationship was found with the very favourable underlying HIV-related virological and immunological status, and the present 8-12-month follow-up did not show disease relapses.

Entities:  

Mesh:

Year:  2006        PMID: 16798716     DOI: 10.1080/00365540500434653

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  5 in total

1.  Aggressive bladder carcinoma in an HIV-positive man with tetraplegia and neurogenic bladder.

Authors:  Justin O Benabdallah; Clinton W Collins; Laura R Carucci; Kenneth E Moores; David R Gater; Adam P Klausner
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

Review 2.  HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management.

Authors:  Elizabeth M Gaughan; Bruce J Dezube; Mark Bower; David M Aboulafia; Gerry Bohac; Timothy P Cooley; Liron Pantanowitz
Journal:  BMC Urol       Date:  2009-08-31       Impact factor: 2.264

Review 3.  Evolving spectrum and incidence of non-AIDS-defining malignancies.

Authors:  Liron Pantanowitz; Bruce J Dezube
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

4.  Glucocorticoid therapy and risk of bladder cancer.

Authors:  K Dietrich; A Schned; J Fortuny; J Heaney; C Marsit; K T Kelsey; M R Karagas
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

Review 5.  Bladder Cancer in HIV-infected Adults: An Emerging Issue? Case-Reports and Systematic Review.

Authors:  Sylvain Chawki; Guillaume Ploussard; Claire Montlahuc; Jérome Verine; Pierre Mongiat-Artus; François Desgrandchamps; Jean-Michel Molina
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.